DMK
ADVM

David M. Knott’s Adverum Biotechnologies ADVM Stock Holding History

David M. Knott’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,600
Closed -$191K – 80
2016
Q4 		$191K Hold
6,600
– – 0.1% 44
2016
Q3 		$271K Buy
+6,600
New +$250K 0.14% 37
2016
Q2 		– Sell
-6,600
Closed -$341K – 84
2016
Q1 		$341K Buy
+6,600
New +$369K 0.09% 52

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David M. Knott's ADVM Position: Q1 2017 in Review

David M. Knott sold out of Adverum Biotechnologies (ADVM) in Q1 2017, closing a stake of 6,600 shares — an estimated $191K sold.

David M. Knott first reported a position in ADVM in Q1 2016 and held it in 3 quarters. The position peaked at $341K in Q1 2016. 75 funds tracked by Wall St. Rank hold ADVM as of Q1 2017.

  • David M. Knott reported no remaining Adverum Biotechnologies position as of Q1 2017 after selling out during the quarter.
  • David M. Knott sold 6,600 Adverum Biotechnologies shares in Q1 2017, an estimated $191K.
  • David M. Knott first reported a position in Adverum Biotechnologies in Q1 2016 and held it in 3 quarters.
  • David M. Knott's Adverum Biotechnologies position peaked at $341K in Q1 2016.
  • 75 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2017.

Based on David M. Knott's 13F filing for Q1 2017, filed 12 May 2017.